Koninklijke Philips stock analysis
Koninklijke Philips (0A2M) Share Price & Analysis
0A2M Stock Chart & Stats
- Day’s Range
- $30.31 - $30.49
- 52-Week Range
- $23.71 - $33.40
- Previous Close
- $30.17
- Volume
- N/A
- Average Volume (3M)
- 4,109
- Market Cap
- $29.39B
- Enterprise Value
- $30.34B
- Total Cash (Recent Filing)
- $2.80B
- Total Debt (Recent Filing)
- $8.28B
- Price to Earnings (P/E)
- 27.2
- Beta
- 1.28
- Next Earnings
- Feb 01, 2027 (Est.)
- EPS Estimate
- 0.64
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 3.28%
Bulls Say, Bears Say
Bulls Say
Innovation And Market-share Gains
Philips is using differentiated imaging and image-guided therapy innovations to win placements against entrenched competitors. Growing order books and new health-system relationships can expand the installed base, supporting future service, software, consumables, and upgrade revenue.
Recurring Healthcare Solutions Growth
Growth in monitoring, informatics, and managed-service offerings increases the share of revenue linked to Philips’ installed base and customer workflows. These recurring or repeat-use solutions can improve revenue visibility and deepen customer relationships beyond periodic equipment purchases.
Operational Margin Improvement
Broad-based margin expansion indicates that higher-margin innovation, gross-margin improvement, productivity actions, and favorable mix are translating into better operating performance. If sustained, this provides greater capacity to fund research, service expansion, and balance-sheet strengthening.
Bears Say
Inconsistent Profitability And Cash Generation
The recent earnings recovery has not yet established a consistently durable financial profile. Prior losses and volatile cash generation make planning and capital allocation less predictable, while weaker year-over-year free cash flow could limit internally funded investment if the pattern persists.
China Pricing And Demand Pressure
Expanding centralized procurement in China creates a structural risk to pricing and health-system volumes, rather than merely a temporary order fluctuation. Continued pressure could constrain revenue growth and margins in an important healthcare market, requiring growth elsewhere to offset it.
Respironics Legal Exposure
Respironics proceedings remain a material source of financial and operational uncertainty even after the DOJ agreement in principle. Settlement payments, additional proceedings, and unresolved obligations can absorb cash, raise costs, and continue diverting management attention from the core health-technology portfolio.
Koninklijke Philips News
0A2M FAQ
What was Koninklijke Philips’s price range in the past 12 months?
What is Koninklijke Philips’s market cap?
When is Koninklijke Philips’s upcoming earnings report date?
How were Koninklijke Philips’s earnings last quarter?
Is Koninklijke Philips overvalued?
Does Koninklijke Philips pay dividends?
What is Koninklijke Philips’s EPS estimate?
How many shares outstanding does Koninklijke Philips have?
What happened to Koninklijke Philips’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Koninklijke Philips?
What is the TipRanks Smart Score and how is it calculated?
Koninklijke Philips Stock Smart Score
Company Description
Koninklijke Philips
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Roy W. O. Jakobs
- Employees
- 66,401
- Website
- www.philips.ca
- Address
- Philips Center, Amsterdam, NH, 1077 WV, NL
Koninklijke Philips (0A2M) Earnings & Revenues
0A2M Company Deck
0A2M Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive. Philips reported strong order momentum, broad-based Personal Health growth, margin expansion ahead of expectations, improved free cash flow, productivity savings, deleveraging and reiterated full-year guidance. The main challenges were flat Diagnosis & Treatment sales caused partly by ultrasound delays, cautious conditions and pricing pressure in China, lower Connected Care order intake due to longer deal cycles, cost inflation, tariffs and ongoing Respironics-related legal matters. Management expressed confidence in the current-year outlook and the medium-term trajectory.
View all GB:0A2M earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 5 | 3 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 11 | 0 | 1 |











